Mutations in the MAPT gene have been associated with neurodegenerative diseases such as Frontotemporal dementia (20, 242–245), PSP (245) and AD (17–21); diseases characterized by abnormal accumulation of pathological forms of tau and that further correlate with cognitive deficits. This evidence concerns the gene MAPT and frontotemporal dementia.